FibroGen, Inc. (FGEN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 1.2700 |
| Open | 1.2600 |
| Bid | 1.1600 x 200 |
| Ask | 1.2100 x 400 |
| Day's Range | 1.1400 - 1.2900 |
| 52 Week Range | 0.3330 - 20.4400 |
| Volume | |
| Avg. Volume | 2,837,777 |
| Market Cap | 115.562M |
| Beta (5Y Monthly) | 0.74 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.9200 |
| Earnings Date | May 06, 2024 - May 10, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.75 |
ZacksUltragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
Ultragenyx (RARE) reports positive interim data from the phase I/II study of GTX-102 for Angelman syndrome. However, the stock declines due to safety concerns.
ZacksXilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
Xilio (XLO) rallies 79.8% in a month on an exclusive global licensing agreement with Gilead Sciences to develop XTX301 for advanced solid tumors.
ZacksRallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
RallyBio (RLYB) gains 83% after announcing a collaboration deal with J&J to develop novel therapies to reduce the risk of FNAIT in pregnant women, along with funding of $6.6 million from the latter.
© 2024 Yahoo. All rights reserved.